Clinical trial
Targeted Silica Nanoparticles for Real-Time Image-Guided Intraoperative Mapping of Nodal Metastases
NCT02106598 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Targeted Silica Nanoparticles for Real-Time Image-Guided Intraoperative Mapping of Nodal Metastases
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Phase
- Phase 1/2
- Overall status
- Active, not recruiting
- Start date
- April 3, 2014
- Completion date
- April 30, 2027
- Enrollment
- 67 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
head and neck melanoma